A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Colony Forming Cell (CFC) Assay for Human Hematopoietic Cells

35.6K views

DOI:

10.3791/2195

December 18th, 2010

In This Article

Summary

The colony forming cell (CFC) assay is an in vitro assay in which hematopoietic progenitors form colonies in a semi-solid medium. A combination of colony morphology, cell morphology, and flow cytometry are used to assess the ability of the progenitors to proliferate and differentiate along the different hematopoietic lineages.

Abstract

Human hematopoietic stem/progenitor cells are usually obtained from bone marrow, cord blood, or peripheral blood and are used to study hematopoiesis and leukemogenesis. They have the capacity to differentiate into lymphoid and myeloid lineages. The colony forming cell (CFC) assay is used to study the proliferation and differentiation pattern of hematopoietic progenitors by their ability to form colonies in a semisolid medium. The number and the morphology of the colonies formed by a fixed number of input cells provide preliminary information about the ability of progenitors to differentiate and proliferate. Cells can be harvested from individual colonies or from the whole plate to further assess their numbers and differentiation states using flow cytometry and morphologic evaluation of Giemsa-stained slides. This assay is useful for assessing myeloid but not lymphoid differentiation. The term myeloid in this context is used in its wider sense to encompass granulocytic, monocytic, erythroid, and megakaryocytic lineages.

We have used this assay to assess the effects of oncogenes on the differentiation of primary human CD34+ cells derived from peripheral blood. For this purpose cells are transduced with either control retroviral construct or a construct expressing the oncogene of interest, in this case NUP98-HOXA9. We employ a commonly used retroviral vector, MSCV-IRES-GFP, that expresses a bicistronic mRNA that produces the gene of interest and a GFP marker. Cells are pre-activated by growing in the presence of cytokines for two days prior to retroviral transduction. After another two days, GFP+ cells are isolated by fluorescence-activated cell sorting (FACS) and mixed with a methylcellulose-containing semisolid medium supplemented with cytokines and incubated till colonies appear on the surface, typically 14 days. The number and morphology of the colonies are documented. Cells are then removed from the plates, washed, counted, and subjected to flow cytometry and morphologic examination. Flow cytometry with antibodies specific to the cell surface markers expressed during hematopoiesis provides information about lineage and maturation stage. Morphological studies of individual cells under a microscope after Wright- Giemsa staining provide further information with regard to lineage and maturation. Comparison of cells transduced with control empty vector to those transduced with an oncogene reveals the effects of the oncogene on hematopoietic differentiation.

Protocol

1. PREPARATION OF REAGENTS

  1. Prepare sterile 1000x stock solutions of Fms-related tyrosine kinase 3 (FLT-3) ligand, granulocyte/macrophage colony-stimulating factor (GM-CSF), stem cell factor (SCF), thrombopoietin (TPO), interleukin (IL)-3, and IL-6 according to manufacturer's instructions. Prepare sterile Retronectin stock solution (1mg/ml) also according to manufacturer's instructions. Divide these stock solutions into small aliquots and keep at -20 °C to avoid repeated freeze-thaw.
  2. Prepare 2% FBS in IMDM.
  3. Prepare complete IMDM medium with final concentrations of 20% FBS, 2 mM Glutamine, 100 units/ml Penicillin/Streptomycin (PS). ....

Access restricted. Please log in or start a trial to view this content.

Discussion

The CFC assay has been used extensively to determine the proliferation and differentiation patterns of hematopoietic progenitors and to study the effects of oncogenes (4, 5). It has the advantage over liquid cultures of being a clonal assay, such that the colonies represent the progeny of a single progenitor and can be individually removed for further analysis. The limitation of the CFC assay is that it is not adequate for the detection of more immature progenitors or hematopoietic stem cells; such cells are detected u.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

No conflicts of interest declared.

Acknowledgements

We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St Louis, MO, for the use of the High Speed Cell Sorter Core, which provided flow cytometry equipment and sorting services. This work was supported by National Institutes of Health Grants R01 HL082549 and K02 HL084179 (NRY). The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant P30 CA91842. ....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
IMDMLife Technologies12440
FBSStem Cell Technologies06150
L-GlutamineLife Technologies25030
Penicillin/Streptomycin (PS)Life Technologies15140
FLT-3 ligandPeproTech Inc300-19
GM-CSFPeproTech Inc300-03
SCFPeproTech Inc300-07
TPOPeproTech Inc300-18
IL3PeproTech Inc200-03
IL6PeproTech Inc200-06
Bovine Serum AlbuminSigma-AldrichA7030
EDTAFisher ScientificBP118
RetronectinTakara Bio IncT100A
HBSSLife Technologies14175
PBSLife Technologies14200
Trypan Blue solution (0.4%)Sigma-AldrichT8154
Methocult GF+ H4435Stem Cell Technologies04445
Human Methylcellulose Enriched MediaR&D SystemsHSC005
Wright/ Giemsa stainHarleco64571
Phosphate Buffer Solution, pH 6.4 - Giordano formulaRicca Chemical Company1450
MethanolFisher ScientificA412-4
Cytoseal 60Thermo Fisher Scientific, Inc.8310
Normal Mouse Serum Rockland ImmunochemicalsD208
Anti-Human CD11b phyc–rythrin-conjugatedBD Biosciences555388
Anti-Human CD33 allophycocyanin-conjugatedBD Biosciences551378
Anti-Human CD45 phyc–rythrin-Cy7-congjugatedBD Biosciences557748
Anti-Human CD71 phyc–rythrin-conjugatedBD Biosciences555537
Anti-Human CD235a allophycocyanin-conjugatedBD Biosciences551336
Anti-Human CD45 phyc–rythrin-Cy7-congjugatedBD Biosciences557748
24-well non-treated tissue culture platesBD Biosciences35-1147
30 mm non-treated dishStem Cell Technologies27150
100 mm tissue culture dish Fisher Scientific08-757-12
Gridded scoring dishesStem Cell Technologies27500
15 ml centrifuge tubesBD Biosciences35-2097
50 ml centrifuge tubesBD Biosciences35-2070
Syringes 3 ml Stem Cell Technologies28240
16 gauge blunt-end, 1½ inch needle Stem Cell Technologies28110
50 μm CellTrics cell filterPartec04-004-2327
HemocytometerFisher Scientific0267110
TPX sample chambersThermo Fisher Scientific, Inc.A78710018
Fisherbrand Superfrost/Plus Microscope Slides, PrecleanedFisher Scientific12-550-15
Shandon filter cardsThermo Fisher Scientific, Inc.5991022
Shandon cytospin slide holderThermo Fisher Scientific, Inc.59920063
Shandon Complete Staining Assembly 100Thermo Fisher Scientific, Inc.100
KimwipesKimberly-Clark Corporation34155
1 μm filter paperVWR international28307-134
Inverted microscopeNikon InstrumentsDiaphot
Microscope cameraNikon InstrumentsDS-F11
MicroscopeOlympus CorporationBX51
Microscope cameraOlympus CorporationDP71
ScannerMicrotekScanmaker 4
Vortex mixerFisher Scientific12-812
Tissue culture incubatorSanyoMCO-18AIC
CytospinShandon, Inc.Cytospin 2
Bench-top centrifugeEppendorf5810-R
Water purification systemBarnsteadNanopure-Diamond

References

  1. Takeda, A., Goolsby, C., Yaseen, N. R. NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells. Cancer Res. , 66-6628 (2006).
  2. Yassin, E. R., Abdul-Nabi, A. M., Takeda, A., Yaseen, N. R.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Hematopoietic Progenitor CellsMyeloid DifferentiationRetroviral TransductionFlow CytometryCD34 Positive CellsMethylcellulose MediumGiemsa StainingCell Sorting